Pursuing a unified data structure for state agencies would save money in the long run but there are challenges to get there, ...
Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
AlphaFold didn't accelerate biology by running faster experiments. It changed the engineering assumptions behind protein ...
Consumer electricity bills are rising across the United States, and data centers may be partially to blame, according to a ...
Value’s Structure Insurance Score offers insurers a clear, integrated way to understand how residential structures may respond to fire, water, and weather risks ...
The Bay Area is the runaway leader in artificial intelligence. But data centers, the physical architecture needed for AI ...
ImagineArt announced the release of an identity-preserving face swap capability integrated directly into the platform’s AI image generator workflow. The update introduces a structured approach to ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
As part of the Resolution Membership Program, collectors will receive 15% off all submissions, expedited turnaround times, ...
After celebrating Donald Trump's second presidential term by swilling cocktails and partying to Snoop Dogg at a ...
A key lesson was to measure what matters. From the outset, we defined clear success metrics—latency reduction, resource ...
After Structure Therapeutics (GPCR) released pivotal topline data from the Phase 2b ACCESS program, H.C. Wainwright argues that the clean safety profile along with 15.3% placebo-adjusted weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results